C/EBPδ targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression

The transcription factor CCAAT/enhancer binding protein δ (C/EBPδ, CEBPD, NFIL-6β) has tumor suppressor function; however, the molecular mechanism(s) by which C/EBPδ exerts its effect are largely unknown. Here, we report that C/EBPδ induces expression of the Cdc27 (APC3) subunit of the anaphase promoting complex/cyclosome (APC/C), which results in the polyubiquitination and degradation of the prooncogenic cell cycle regulator cyclin D1, and also down-regulates cyclin B1, Skp2, and Plk-1. In C/EBPδ knockout mouse embryo fibroblasts (MEF) Cdc27 levels were reduced, whereas cyclin D1 levels were increased even in the presence of activated GSK-3β. Silencing of C/EBPδ, Cdc27, or the APC/C coactivator Cdh1 (FZR1) in MCF-10A breast epithelial cells increased cyclin D1 protein expression. Like C/EBPδ, and in contrast to cyclin D1, Cdc27 was down-regulated in several breast cancer cell lines, suggesting that Cdc27 itself may be a tumor suppressor. Cyclin D1 is a known substrate of polyubiquitination complex SKP1/CUL1/F-box (SCF), and our studies show that Cdc27 directs cyclin D1 to alternative degradation by APC/C. These findings shed light on the role and regulation of APC/C, which is critical for most cellular processes.

[1]  I. Ellis,et al.  A gene-expression signature to predict survival in breast cancer across independent data sets , 2007, Oncogene.

[2]  C. Bassing,et al.  Genotoxic Stress-Induced Cyclin D1 Phosphorylation and Proteolysis Are Required for Genomic Stability , 2008, Molecular and Cellular Biology.

[3]  W. Hofmann,et al.  The C/EBPdelta tumor suppressor is silenced by hypermethylation in acute myeloid leukemia. , 2007, Blood.

[4]  Akinobu Matsumoto,et al.  Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin‐dependent degradation , 2006, Cancer science.

[5]  C. Sherr,et al.  Gene Expression and Cell Cycle Arrest Mediated by Transcription Factor DMP1 Is Antagonized by D-Type Cyclins through a Cyclin-Dependent-Kinase-Independent Mechanism , 1998, Molecular and Cellular Biology.

[6]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[7]  Kornelia Polyak,et al.  Molecular markers in ductal carcinoma in situ of the breast. , 2003, Molecular cancer research : MCR.

[8]  J. Meller,et al.  A central domain of cyclin D1 mediates nuclear receptor corepressor activity , 2005, Oncogene.

[9]  M. Kirschner,et al.  A 20s complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B , 1995, Cell.

[10]  A. Thompson,et al.  Cyclin D1 and breast cancer. , 2006, Breast.

[11]  Yves Pommier,et al.  γH2AX and cancer , 2008, Nature Reviews Cancer.

[12]  J. Dewille,et al.  Promoter methylation reduces C/EBPδ (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors , 2005, Breast Cancer Research and Treatment.

[13]  T. Golub,et al.  A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer , 2003, Cell.

[14]  V. Barresi,et al.  The cell growth inhibitory transcription factor C/EBPδ is expressed in human meningiomas in association with low histological grade and proliferation index , 2010, Journal of Neuro-Oncology.

[15]  A. Klein-Szanto,et al.  Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex. , 2006, Molecular cell.

[16]  W. Hofmann,et al.  C/EBPδ expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation , 2005, Oncogene.

[17]  Y. Geng,et al.  Specific protection against breast cancers by cyclin D1 ablation , 2001, Nature.

[18]  Z. Hall.  Cancer , 1906, The Hospital.

[19]  T. Ried,et al.  Loss of CCAAT/enhancer binding protein δ promotes chromosomal instability , 2004, Oncogene.

[20]  Emma Lees,et al.  Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice , 1994, Nature.

[21]  E. Di Iorio,et al.  C/EBPδ regulates cell cycle and self-renewal of human limbal stem cells , 2007, The Journal of cell biology.

[22]  J. Diehl,et al.  Nuclear cyclin D1: An oncogenic driver in human cancer , 2009, Journal of cellular physiology.

[23]  S. Gery,et al.  CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells. , 2005, Cancer research.

[24]  I. Sumara,et al.  E3 ubiquitin ligases and mitosis: embracing the complexity. , 2008, Trends in cell biology.

[25]  S. Kitareewan,et al.  Cyclin degradation for cancer therapy and chemoprevention , 2007, Journal of cellular biochemistry.

[26]  A. El-Osta,et al.  γH2AX: a sensitive molecular marker of DNA damage and repair , 2010, Leukemia.

[27]  Y. Umayahara,et al.  CCAAT/Enhancer-binding Protein δ Activates Insulin-like Growth Factor-I Gene Transcription in Osteoblasts , 1997, The Journal of Biological Chemistry.

[28]  M. Pagano,et al.  Control of cell growth by the SCF and APC/C ubiquitin ligases. , 2009, Current opinion in cell biology.

[29]  R. Bernards,et al.  Distinct Initiation and Maintenance Mechanisms Cooperate to Induce G1 Cell Cycle Arrest in Response to DNA Damage , 2000, Cell.

[30]  Maria Miller,et al.  Structural Basis for DNA Recognition by the Basic Region Leucine Zipper Transcription Factor CCAAT/Enhancer-binding Protein α* , 2003, The Journal of Biological Chemistry.

[31]  A. Klein-Szanto,et al.  Phosphorylation-Dependent Ubiquitination of Cyclin D1 by the SCFFBX4-αB Crystallin Complex , 2006 .

[32]  F. Takahashi‐Yanaga,et al.  GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy. , 2008, Cellular signalling.

[33]  S. Rabindran,et al.  Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression , 2005, Breast Cancer Research and Treatment.

[34]  J. O’Rourke,et al.  CCAAT/Enhancer-binding Protein-δ (C/EBP-δ) Is Induced in Growth-arrested Mouse Mammary Epithelial Cells* , 1997, The Journal of Biological Chemistry.

[35]  A. Udvardy,et al.  Structurally related TPR subunits contribute differently to the function of the anaphase-promoting complex in Drosophila melanogaster , 2007, Journal of Cell Science.

[36]  F. Cross,et al.  The emerging role of APC/CCdh1 in controlling differentiation, genomic stability and tumor suppression , 2010, Oncogene.

[37]  H. Hsu,et al.  Epigenetic Silencing of CCAAT/Enhancer-binding Protein δ Activity by YY1/Polycomb Group/DNA Methyltransferase Complex* , 2008, Journal of Biological Chemistry.

[38]  W. Hofmann,et al.  The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia , 2007 .

[39]  M. Raffeld,et al.  C/EBPδ is a crucial regulator of pro-apoptotic gene expression during mammary gland involution , 2005, Development.

[40]  Lawrence A. Donehower,et al.  Cyclin D1 Repression of Peroxisome Proliferator-Activated Receptor γ Expression and Transactivation , 2003, Molecular and Cellular Biology.

[41]  J. Peters.  The anaphase promoting complex/cyclosome: a machine designed to destroy , 2006, Nature Reviews Molecular Cell Biology.

[42]  J. Alao,et al.  Molecular Cancer BioMed Central Review The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention , 2007 .

[43]  Jia Luo,et al.  Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. , 2009, Cancer letters.

[44]  T. Tiganis,et al.  DNA replication stalling attenuates tyrosine kinase signaling to suppress S phase progression. , 2008, Cancer cell.